Mechanistically, HIPK4 promoted tumor progression by phosphorylating the tumor suppressor TAp63 at Ser395, leading to decreased expression of EFEMP1, a key extracellular matrix protein with anti-tumor properties. Here, EFEMP1 is linked to neoplasm.